Emibetuzumab
id:
emibetuzumab-286-2153817
title:
Emibetuzumab
text:
Emibetuzumab (INN) (LY2875358) is a humanized monoclonal antibody designed for the treatment of cancer. It is in phase II trials for patients with NSCLC This drug was developed by Eli Lilly & Company.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Emibetuzumab
date created:
date modified:
2023-04-03T04:24:22Z
main entity:
{"identifier":"Q19904056","url":"https://www.wikidata.org/entity/Q19904056"}
image:
fields total:
13
integrity:
14